Patient groups want COX-2 study

The American Heart Association and the Arthritis Foundation are calling for a large, long-term study to assess the cardiovascular safety of selective COX-2 inhibitors, representatives of the organizations told BioCentury on Friday. The studies are needed to address concerns raised by an Aug. 21 paper in the Journal of the American Medical Association, AHA spokesperson Richard Stein said (see BioCentury August 27, 2001). ...